Patents/Assignees

Bristol-myers Squibb Company

249 patents in portfolio

US12154362utility2024
Framework for Document Layout and Information Extraction
0 cites
US12145927utility2024
Inhibitors of Indoleamine 2,3-dioxygenase and Methods of Their Use
0 cites
US12139551utility2024
Anti-ido Antibody and Uses Thereof
0 cites
US12129297utility2024
Antibodies Against TIM3 and Uses Thereof
0 cites
US12129245utility2024
Crystal Form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl-d 3 ) Pyridazine-3-carboxamide
0 cites
US12129264utility2024
Crystalline Forms of a PAR4 Inhibitor
0 cites
US12110290utility2024
Triazolopyridinyl Compounds as Kinase Inhibitors
0 cites
US12110337utility2024
Anti-cd27 Antibodies and Uses Thereof
0 cites
US12102595utility2024
Serially-connectable Drug Modules for Combinatorial Drug Delivery Device
0 cites
US12103949utility2024
Protein Recovery
0 cites
US12099041utility2024
Automated Parallel Autosampler System and Method for Drawing Chromatography Samples
0 cites
US12097242utility2024
Treatment of Fibrosis, Cardiovascular Disease and Heart Failure with Modified Relaxin Polypeptides
0 cites
US12097241utility2024
Methods of Treating Kidney Failure, And/or Improving or Stablizing Renal Function Using Modified Relaxin Polypeptides
0 cites
US12091462utility2024
Antibodies Binding to Vista at Acidic Ph
0 cites
US12084426utility2024
Indazole Carboxamides as Kinase Inhibitors
0 cites
US12085564utility2024
Assay to Determine in Vivo Receptor Occupancy
0 cites
US12077584utility2024
Methods of Treating Hla-e-expressing Cancers by Administering Antibodies Which Bind Human Natural Killer Cell Inhibitory Receptor Group 2A (NKG2A)
0 cites
US12080087utility2024
Classifying Pharmacovigilance Documents Using Image Analysis
0 cites
US12065437utility2024
Biaryl Kinase Inhibitors
0 cites
US12065505utility2024
Antibodies and Antigen Binding Peptides for Factor Xia Inhibitors and Uses Thereof
0 cites

← PreviousPage 7 of 13Next →